龙沙选择TRU全球解决方案提供洁净室服务 - 洁净室技术
Lonza chooses TRU Global Solutions for cleanroom services - Cleanroom Technology
#TRU Global#Global Solutions#chooses TRU#Cleanroom Technology#Lonza chooses
生命科学资讯
生物技术与制药领域的最新动态
龙沙任命安德烈亚斯·博雷尔为首席法律与公司事务官——合同制药
Lonza Appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer - Contract Pharma
#Chief Legal#Corporate Affairs#Appoints Andreas#Andreas Bohrer#Affairs Officer
收益电话会议记录：龙沙在2025年第一季度确认强劲的2025年展望 - Investing.com
Earnings call transcript: Lonza Confirms Strong 2025 Outlook in Q1 2025 - Investing.com
#Lonza Confirms#Confirms Strong#call transcript#Earnings call#Investing.com Earnings
Lonza集团（LZAGY）作为强劲势头股，值得买入吗？——纳斯达克
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? - Nasdaq
#Momentum Stock#Great Momentum#Lonza Group#LZAGY#Stock
龙沙CHI创新战略内幕：面向未来的复杂药物胶囊技术 - 制药科技网
Inside Lonza CHI’s Innovation Strategy: Future-Ready Capsules for Complex Drugs - PharmTech.com
#Innovation Strategy#Lonza CHI#Future-Ready Capsules#Complex Drugs#Inside Lonza
Ethris与Lonza专注于mRNA呼吸道疾病疫苗研发 - 制药技术
Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology
#Pharmaceutical Technology#Lonza focus#mRNA respiratory#respiratory condition#Technology Ethris
Ethris与龙沙携手开发喷雾干燥mRNA疫苗，预防呼吸道疾病——BioSpace报道
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - BioSpace
#Lonza Collaborate#Respiratory Disease#Disease Prevention#Develop Spray-Dried#mRNA Vaccines
Ethris与Lonza携手开发喷雾干燥mRNA疫苗 - 合同制药报道
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines - Contract Pharma
#Lonza Collaborate#Contract Pharma#Develop Spray-Dried#mRNA Vaccines#Vaccines Contract
Ethris与Lonza合作开发用于预防呼吸道疾病的喷雾干燥mRNA疫苗——GEN生物技术新闻
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Lonza Collaborate#Respiratory Disease#Disease Prevention#Develop Spray-Dried
与龙沙胶囊与健康成分的同步进展——《营养展望》
Catching up with Lonza Capsules and Health Ingredients - Nutritional Outlook
#Lonza Capsules#Health Ingredients#Nutritional Outlook#Ingredients Nutritional#Outlook Catching
龙沙集团投资大规模生物制造、生物偶联及药品生产领域——DCAT价值链洞察
Lonza Investing in Large-Scale Biomanufacturing, Bioconjugation, Drug-Product Manufacturing - DCAT Value Chain Insights
#Large-Scale Biomanufacturing#Chain Insights#Drug-Product Manufacturing#Lonza Investing#Manufacturing DCAT
龙沙推行精简运营模式——合同制药
Lonza Implements Streamlined Operating Model - Contract Pharma
#Implements Streamlined#Streamlined Operating#Operating Model#Contract Pharma#Lonza Implements
龙沙集团领导参观新罕布什尔大学组织培养实验室
Lonza Leadership Visits UNH's Tissue Culture Lab - University of New Hampshire
#Leadership Visits#Visits UNH#UNH Tissue#Tissue Culture#Culture Lab
Exogenus Therapeutics选定龙沙集团生产Exo-101——合同制药
Exogenus Therapeutics Chooses Lonza to Manufacture Exo-101 - Contract Pharma
#Contract Pharma#Therapeutics Chooses#Chooses Lonza#Exogenus Therapeutics#Pharma Exogenus
Exogenus Therapeutics与Lonza合作开发符合GMP标准的主要外泌体候选药物生产工艺 - 基因工程与生物技术新闻
Exogenus Therapeutics Taps Lonza to Develop a GMP-Compliant Process for Lead Exosome-Based Candidate - GEN - Genetic Engineering and Biotechnology News
#Genetic Engineering#Therapeutics Taps#Taps Lonza#Exogenus Therapeutics#GMP-Compliant Process
Vaxcyte将Lonza位于Visp工厂的制造投资列为2024年关键支出——生物工艺国际报道
Vaxcyte cites manufacturing investments at Lonza facility in Visp as key 2024 expenditure - BioProcess International
#Lonza facility#Vaxcyte cites#BioProcess International#cites manufacturing#manufacturing investments
龙沙与UNH合作推出生命科学奖学金及导师计划 | UNH今日 - 新罕布什尔大学
Lonza Partners with UNH to Offer Life Sciences Scholarship and Mentorship Program | UNH Today - University of New Hampshire
#Mentorship Program#Offer Life#Life Sciences#Sciences Scholarship#UNH Today
尽管龙沙2024年销售额下滑，但CDMO业务展望新年势头更劲——Fierce Pharma报道
While Lonza's sales slipped in '24, CDMO touts stronger position heading into new year - Fierce Pharma
#CDMO touts#Fierce Pharma#Lonza sales#sales slipped#touts stronger
CDMO企业药明生物收购龙沙在华生物制药厂，加速布局亚太市场——Fierce Pharma报道
CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market - Fierce Pharma
#CDMO Joinn#Joinn Biologics#China biologics#Fierce Pharma#Biologics snaps
JPM 2025：龙沙集团分享CHI退出与收购战略展望——聚焦制药技术领域
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy - Pharmaceutical Technology
#Lonza shares#Pharmaceutical Technology#CHI exit#Technology JPM#shares outlook